Order Now 1-800-246-8878

Celebrate the 7th Anniversary with DiaCarta and Take your Rewards to Lab!

Enjoy a 30% off with our QClamp® single gene mutation detection kits, including KRAS, NRAS, EGFR, BRAF and JAK2. Reward ends on September 30, 2018.

Order Now

QClamp® KRAS Codon Specific Mutation Test (CE/IVD)

Ultra-Sensitive on Liquid Biopsy & FFPE, powered by XNA Technology

Learn more

Launched: OptiSeq™ Pan-Cancer Panel

Sample to clinical report within 10 days, performed in a CLIA certified laboratory

Learn more

We are hiring! Join our growing team and build your career at DiaCarta!

We are seeking talented, imaginative, creative & ambitious people to join us in advancing molecular diagnostic development & clinical testing

Open Positions

QClamp®: The Most Sensitive Real-Time PCR Assay Powered by XNA Molecular Technology

Ideal tool for ultra-low-frequency cancer mutation detection and NGS data validation

Learn more

QFusion™: Single-Tube qPCR Assay for ALK Fusion Gene Detection

The most comprehensive, rapid and reliable alternative to the laborious fluorescence in situ hybridization (FISH) test

Learn more

Redefining Precision Molecular Diagnostics

DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world.

DiaCarta Proprietary Technologies and Products

Highly Sensitive

Less than 0.01% sensitivity on difficult or diminished samples

Rapid Results for Faster Diagnosis

First-time results on any sample size in less than two hours

Superior Compatibility

The first and only
platform-agnostic technology

Highest-Quality Certifications

GMP-compliant facility with CA CLIA certification